Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00743314 | Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer | completed | Early Phase 1 | 30 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02802748 | Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA) | completed | Early Phase 1 | 60 | SOLTI Breast Cancer Research GroupOTHER | 1 | Sep 20, 2018 |
| clinicaltrials |
| NCT00986609 | MUC1 Vaccine for Triple-negative Breast Cancer | completed | Early Phase 1 | 29 | Joseph Baar, MD, PhDOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03546478 | 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization | completed | Early Phase 1 | 32 | Peking Union Medical College HospitalOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01793948 | Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer | completed | Early Phase 1 | 24 | Anna Maria StornioloOTHER | 1 | Mar 30, 2018 | clinicaltrials |
| NCT02077998 | Oxaliplatin in Treating Patients With Metastatic Breast Cancer | completed | Early Phase 1 | 1 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT02463383 | Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal Women(EPPNASE) | completed | Early Phase 1 | 25 | Professor Lars Ove DragstedOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT00725946 | Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT | terminated | Early Phase 1 | 7 | Stanford UniversityOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT01864083 | FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients | completed | Early Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT01784042 | Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue | withdrawn | Early Phase 1 | 0 | Milton S. Hershey Medical CenterOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT03113019 | Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer(BC-LDC) | unknown | Early Phase 1 | 26 | Research Institute of Fundamental and Clinical ImmunologyOTHER_GOV | 0 | Apr 13, 2017 | clinicaltrials |
| NCT00993642 | ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer | withdrawn | Early Phase 1 | 0 | Tulane University Health Sciences CenterOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT01468649 | Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer | completed | Early Phase 1 | 50 | Beth Israel Deaconess Medical CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT01313039 | Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer | completed | Early Phase 1 | 4 | University of MiamiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01659645 | Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast | completed | Early Phase 1 | 12 | Emory UniversityOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT02380209 | An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer | terminated | Early Phase 1 | 8 | University of ArizonaOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT00534755 | Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to Present | completed | Early Phase 1 | 10,000 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01302002 | The Use of Metformin in Early Breast Cancer Patients Pre-Surgery | withdrawn | Early Phase 1 | 0 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02679586 | Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy | completed | Early Phase 1 | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 11, 2016 | clinicaltrials |
| NCT00527293 | Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer | completed | Early Phase 1 | 29 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 25, 2015 | clinicaltrials |
| NCT00826488 | A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses | completed | Early Phase 1 | 136 | Washington University School of MedicineOTHER | 1 | Jun 2, 2015 | clinicaltrials |
| NCT02207179 | Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology | unknown | Early Phase 1 | 40 | LumaMedINDUSTRY | 1 | Mar 31, 2015 | clinicaltrials |
| NCT01805089 | Melatonin Versus Placebo in Breast Cancer | completed | Early Phase 1 | 95 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT02139371 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | completed | Early Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Dec 12, 2014 | clinicaltrials |
| NCT01513356 | Pharmacodynamic Study of BKM120 in Breast Cancer | completed | Early Phase 1 | 20 | Sofia Perea, Director Clinical Trials Unit.OTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01697345 | Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy | completed | Early Phase 1 | 12 | Creighton UniversityOTHER | 1 | Jan 24, 2014 | clinicaltrials |
| NCT00301041 | Radiation Therapy in Treating Women With Invasive Breast Cancer | completed | Early Phase 1 | 20 | University of California, San FranciscoOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT01923220 | Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis(ARD) | unknown | Early Phase 1 | 90 | HealOrINDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT01684579 | Exercising Our ABC's (African- American Breast Cancer Survivors) | completed | Early Phase 1 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2013 | clinicaltrials |
| NCT01055678 | To Evaluate the Characteristics of a Breast Cancer | withdrawn | Early Phase 1 | 0 | Mark DewhirstOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00991978 | VEGF Early Imaging for Breast Cancer | completed | Early Phase 1 | 23 | University Medical Center GroningenOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT00572598 | Pilot Study of 18F Fluoropaclitaxel (FPAC) | completed | Early Phase 1 | 6 | Virginia Commonwealth UniversityOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00945607 | Guided Relaxation Training for the Reduction of Self-Reported Stress in Individuals With Newly Diagnosed Breast Cancer(09-IM-01) | unknown | Early Phase 1 | 40 | Trinitas Comprehensive Cancer CenterOTHER | 1 | Jul 25, 2011 | clinicaltrials |
| NCT01089699 | A Trial Testing Professional and Peer-led Support Online Support Groups for Young Canadian Breast Cancer Survivors(CBCRA09) | unknown | Early Phase 1 | 210 | British Columbia Cancer AgencyOTHER | 0 | Mar 18, 2010 | clinicaltrials |
| NCT00743353 | Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5(K5) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Feb 2, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Oct 9, 2018source: clinicaltrials